Skip to main content
RYTM
NASDAQ Life Sciences

AstraZeneca Reportedly Made ~$10B Takeover Approach for Rhythm Pharmaceuticals

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$95.21
Mkt Cap
$6.555B
52W Low
$74.5
52W High
$122.2
52W Position info
28% above low
Off High info
22% below high
Rel. Volume info
4.2× avg
Market data snapshot near publication time

RYTM sits 28% above its 52-week low of $74.5 on elevated volume (4.2× avg).

Summary

AstraZeneca made a roughly $10 billion offer for Rhythm Pharmaceuticals last month, at $124 per share, according to WSJ-sourced reporting carried by Dow Jones. That is a large premium to Rhythm's current market value, which sits well below the offer figure, so the stock is likely to reprice toward deal terms. The approach lands right after a busy stretch: Rhythm signed an $855 million license-out with LG Chem on Nov. 3, posted Q3 revenue of $92.1 million (up 79% year over year), and disclosed a new $750 million five-year term loan. Those moves built out the IMCIVREE franchise — recent UK, Japan and Canada approvals plus the Japan launch — which is presumably what AstraZeneca is buying. The key question now is whether this is a firm bid or an early approach; no board response or definitive agreement has been disclosed.

At the time of this announcement, RYTM was trading at $95.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.6B. The 52-week trading range was $74.50 to $122.20. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

RYTM - Latest Insights

RYTM
Nov 16, 2026, 4:00 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $107.31
Real-time Price: $116.92 info
Change: +$9.61 (+9%) info
Market Cap: $8.098B info
RYTM
Nov 06, 2026, 11:06 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $109.39
Real-time Price: $116.92 info
Change: +$7.53 (+7%) info
Market Cap: $8.098B info
RYTM
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $109.75
Real-time Price: $116.92 info
Change: +$7.17 (+7%) info
Market Cap: $8.098B info
RYTM
Nov 04, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $85.70
Real-time Price: $116.92 info
Change: +$31.22 (+36%) info
Market Cap: $8.098B info
RYTM
Nov 04, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $88.42
Real-time Price: $116.92 info
Change: +$28.50 (+32%) info
Market Cap: $8.098B info